Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy

Figure 7

(a) The cell cycle analysis of HepG2 cells was exposed to three DOX formulations (DOX, Se@DOX and HA-Se@DOX) for 24 h, respectively. (b) The cells were exposed to three DOX formulations for 24 h, respectively, and then stained with DCFDA for 15 min. The ROS level of the treated HepG2 cells was examined using a fluorescence microscope. Scale bar indicates 20 μm.

(a)

(b)